[Federal Register: October 18, 1999 (Volume 64, Number 200)]
[Notices]               
[Page 56226]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18oc99-78]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is, notice that on June 21, 1999, Chirex 
Technology Center, Inc., DBA Chirex Cauldron, 383 Phoenixville Pike, 
Malvern, Pennsylvania 19355, made application to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of 
Amphetamine (1100), a basic class of controlled substance listed 
Schedule II.
    The firm plans to bulk manufacture amphetamine salts for product 
development.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than December 17, 1999.

    Dated: October 8, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-27101 Filed 10-15-99; 8:45 am]
BILLING CODE 4410-09-M